Oncternal Therapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Oncternal Therapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Oncternal Therapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Oncternal Therapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Oncternal Therapeutics Clinical Trials
Determine Oncternal Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Oncternal Therapeutics Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies | GDCT0382100 | ONCT-808 | Oncology | B-Cell Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Hematological Tumor; Mantle Cell Lymphoma; Primary Mediastinal B-Cell Lymphoma; Solid Tumor; Unspecified B-Cell Lymphomas | Phase I/II | Ongoing, recruiting | Oncternal Therapeutics |
| A Phase I Study of TK-216 in Subjects with Relapsed Acute Myeloid Leukemia | GDCT0370355 | ONCT-216 | Oncology | Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia); Relapsed Acute Myeloid Leukemia | Phase I | Withdrawn | Oncternal Therapeutics |
| Study to Assess Long-term Safety/Tolerability of Enobosarm (GTx 024) in Stress Urinary Incontinence | GDCT0326287 | enobosarm | Genito Urinary System And Sex Hormones | Stress Urinary Incontinence | Phase II | Terminated | Oncternal Therapeutics |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer